News

Becton, Dickinson and Company will release its third-quarter earnings next month, and analysts anticipate a single-digit ...
Aristotle Atlantic Partners, LLC, an investment advisor, released its “Core Equity Strategy” second quarter 2025 investor ...
Becton Dickinson (BDX) recently announced the initiation of a pharma-sponsored clinical trial featuring their BD Libertas Wearable Injector, alongside an affirmed quarterly dividend and leadership ...
This was the stock's second consecutive day of losses.
The El Paso Children's Hospital Foundation receives a $30,000 grant to support families with hospitalized children, covering non-medical needs.
Becton, Dickinson (NYSE:BDX) declares $1.04/share quarterly dividend, in line with previous. Forward yield 2.29% Payable Sept. 30; for shareholders of record Sept. 8; ex-div Sept. 8. See BDX Dividend ...
Universal Health Realty's dividend has been hiked annually for four decades. That's a pretty good streak, even though it ...
Becton Dickinson (BDX) announced the first pharma-sponsored combination product clinical trial using the BD Libertas Wearable Injector for ...
Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.
Eosinophil-derived neurotoxin (EDN), as a biomarker of eosinophilic activity, can be measured in blood matrices ...